Pembrolizumab and the significance of PD-L1 for lung cancer
0:56
Pembrolizumab and the significance of PD-L1 for lung cancer
986 viewsOct 24, 2016
YouTubeVJOncology
KEYNOTE-158: Pembrolizumab Use in Advanced Endometrial Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
KEYNOTE-158: Pembrolizumab Use in Advanced Endometrial Cancer …
Mar 1, 2022
targetedonc.com
KEYNOTE-522: Pembrolizumab in Triple-Negative Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
KEYNOTE-522: Pembrolizumab in Triple-Negative Breast Cancer | Ta…
Nov 9, 2023
targetedonc.com
Preliminary Data of MK-1084 /- Pembrolizumab in Solid Tumors and NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Preliminary Data of MK-1084 /- Pembrolizumab in Solid Tumors a…
Nov 17, 2023
targetedonc.com
KEYNOTE-522: Event-Free Survival With Neoadjuvant and Adjuvant Pembrolizumab in TNBC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
6:31
KEYNOTE-522: Event-Free Survival With Neoadjuvant and Adjuvant P…
1 week ago
targetedonc.com
Dr. Hamid on the FDA Approval of Pembrolizumab in Merkel Cell Carcinoma | OncLive
Dr. Hamid on the FDA Approval of Pembrolizumab in Merkel Cell Car…
2 weeks ago
onclive.com
Using First-Line Immunotherapy in Stage 4 NSCLC
2:08
Using First-Line Immunotherapy in Stage 4 NSCLC
508 viewsJul 19, 2018
YouTubeTargeted Oncology
NICE recommends pembrolizumab for 1,600 more people with breast …
Nov 14, 2022
cancerresearchuk.org
Dr. Brahmer Discusses Second-Line Pembrolizumab in NSCLC
Mar 15, 2018
onclive.com
1:58
ASCENT-04: sacituzumab govitecan and pembrolizumab in PD-L1-posi…
695 viewsSep 22, 2022
YouTubeVJOncology
KEYNOTE-522: Neoadjuvant and Adjuvant Pembrolizumab in TNB…
Jun 1, 2022
onclive.com
4:00
Merck's Keytruda (pembrolizumab) mechanism of action explained
3.4K viewsNov 14, 2023
YouTubeHypertunity
2:55
How Keytruda Cancer Treatment Works (Update)
83.1K viewsOct 15, 2018
YouTubeLighter Side of Cancer
2:38
First-Line Carboplatin and Pemetrexed With Pembrolizumab f…
5K viewsJun 20, 2017
YouTubeTargeted Oncology
4:27
Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biom…
35.2K viewsMay 14, 2024
YouTubeYou and Lung Cancer
8:38
#Pembrolizumab | Uses, Dosage, Side Effects and Mechanism | Key…
8.2K viewsSep 8, 2023
YouTubeHe-InFo
13:24
💊What is PEMBROLIZUMAB?. Mechanism of Action, Dosage an…
1.6K viewsJun 4, 2020
YouTubeMedicines/Diseases
2:12
Cancer immunotherapy | The PD-L1 pathway
214.7K viewsMay 26, 2016
YouTubeRoche
1:44
Efficacy and Biomarker Results for Pembrolizumab in Soft Tissue an…
219 viewsJun 2, 2017
YouTubeTargeted Oncology
9:19
Exploring the PD-1/PD-L1 pathway using Data, Tools, and Resources …
2.8K viewsFeb 8, 2023
YouTubeRCSBProteinDataBank
Dr. Herbst on the FDA Approval of Adjuvant Pembrolizumab in NSCL…
Feb 2, 2023
onclive.com
4:15
Keytruda Pembrolizumab Immunotherapy uses and side effe…
11.9K viewsOct 6, 2022
YouTubeTECHNO LEARNING
4:12
Immunotherapy for Cancer: Pembrolizumab #cancer #immuno…
13.3K viewsOct 13, 2022
YouTubeCancer Therapeutics
KEYNOTE-062: Pembrolizumab for PD-L1 CPS ≥10 Advanced Gastric …
Feb 24, 2021
medscape.com
2:02
Progression on Pembrolizumab: Patient Without Actionable Mutati…
87 viewsMar 2, 2023
YouTubeGlobal Resource for Advancing Cancer Education
7:03
LBA8_PR - KEYNOTE-048: Phase 3 study of first-line pembrolizumab i…
2.8K viewsOct 22, 2018
YouTubeOncoletter
1:46
Pembrolizumab
5.8K viewsJan 30, 2019
YouTubeThe Ruesch Center
2:05
Long-term efficacy of pembrolizumab in advanced mela…
805 viewsJun 1, 2017
YouTubeGustave Roussy
32:29
Cancer chemotherapy (Ar): Lec 04 - PD-1/PD-L1 (immune checkpoint) i…
125.4K viewsJun 30, 2022
YouTubeClinical Pharmacology Lectures
Pembrolizumab new option for firstline treatment of advanced lun…
300 viewsJan 13, 2017
YouTubeecancer
See more videos
Static thumbnail place holder